Laser Ablation: An Emerging Treatment for Drug-Resistant Epilepsy
Neurosurgeons at NewYork-Presbyterian/Columbia report on this minimally invasive approach that can be highly effective for select patients.
Post-Stroke Evaluation: How Safe is Transesophageal Echocardiography?
Weill Cornell Medicine neurologists, cardiologists, and pulmonary and critical care medicine specialists present findings on the risk of respiratory failure in patients undergoing TEE.
Promising ALS Therapy Moves Closer to the Clinic
NewYork-Presbyterian/Columbia University Irving Medical Center is leading a global phase 1-3 clinical trial of an experimental drug – jacifusen – that may alter the progression of amyotrophic lateral sclerosis.
Major Grant Propels Research in Early Stage Parkinson’s Disease
Weill Cornell Medicine neuroscience team to study how abnormal protein aggregates may spread from the gut to the brain to drive the early stages of Parkinson’s disease.
Furthering Awareness in Recovery of Consciousness
Neurologists and critical care medicine specialists at NewYork-Presbyterian Hospital offer highly specialized expertise in disorders of consciousness to promote the best outcomes for patients.
NeuroNEXT 2021 Issue 1
Learn more about current neuroscience clinical trials at NewYork-Presbyterian.
Donald O. Quest, MD, Honored for Lifetime of Service
The Society of Neurological Surgeons (SNS) has awarded Donald O. Quest, MD, J. Lawrence Pool Professor of Neurological Surgery at Columbia University, the 2020 Distinguished Service Award for a lifetime of service to graduate and postgraduate education and research.
Dr. E. Sander Connolly Jr. Named Neurosurgeon-in-Chief at Columbia
On August 1, 2020, E. Sander Connolly Jr., MD, became the seventh Neurosurgeon-in-Chief at NewYork-Presbyterian/Columbia University Irving Medical Center and Chair of the Department of Neurological Surgery at Columbia University Vagelos College of Physicians and Surgeons.
Page1 of 3